Tumor necrosis factor-related apoptosis-inducing ligand mediates the resolution of allergic airway inflammation induced by chronic allergen inhalation

Mucosal Immunology

Volumn 7, Issue 5, 2014, Pages 1199-1208

  Faustino, L ^a   Fonseca, D M ^a   Florsheim, E B ^a   Resende, R R ^b   Lepique, A P ^a   Faquim Mauro, E ^c   Gomes, E ^a   Silva, J S ^a   Yagita, H ^d   Russo, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CASPASE 3; CASPASE 8; FAS LIGAND; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; PROGRAMMED DEATH 1 RECEPTOR; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; SUPERKILLERTRAIL; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; LIPOCORTIN 5;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EOSINOPHIL; EOSINOPHILIA; EXPOSURE; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; LEUKOCYTE; LIGAND BINDING; LOCAL INHALATIONAL TOLERANCE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH2 CELL; ANIMAL; CHRONIC DISEASE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LUNG; METABOLISM; PATHOPHYSIOLOGY; RESPIRATORY HYPERSENSITIVITY; ASTHMA; CELL INFILTRATION; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; PROTEIN ANALYSIS; STAINING;

ALLERGENS; ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CASPASE 3; CASPASE 8; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; LUNG; MICE; MICE, KNOCKOUT; RECOMBINANT PROTEINS; RESPIRATORY HYPERSENSITIVITY; TH2 CELLS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84905654596     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.9     Document Type: Article

References (79)

1. Foster, P.S. et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 179, 173-181 (2001).
2. Robinson, D.S. et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326, 298-304 (1992).
3. Temann, U.A., Ray, P. & Flavell, R.A. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 109, 29-39 (2002).
4. Zhu, Z. et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103, 779-788 (1999).
5. Subbarao, P., Mandhane, P.J. & Sears, M.R. Asthma: epidemiology, etiology and risk factors. CMAJ 181, E181-E190 (2009).
6. Durham, S.R. et al. Long-term clinical efficacy of grass-pollen immunotherapy. N. Engl. J. Med. 341, 468-475 (1999).
7. Jacobsen, L. et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62, 943-948 (2007).
8. Jacobsen, L., Wahn, U. & Bilo, M.B. Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy. Clin. Transl. Allergy 2, 8 (2012).
9. Epstein, M.M. Do mouse models of allergic asthmamimic clinical disease? Int. Arch. Allergy Immunol. 133, 84-100 (2004).
10. Schroder, N.W. & Maurer, M. The role of innate immunity in asthma: leads and lessons from mouse models. Allergy 62, 579-590 (2007).
11. Russo, M. et al. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am. J. Resp. Cell Mol. Biol. 24, 518-526 (2001).
12. Keller, A.C. et al. Hierarchical suppression of asthma-like responses by mucosal tolerance. J. Allergy Clin. Immunol. 117, 283-290 (2006).
13. Mucida, D. et al. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115, 1923-1933 (2005).
14. Mucida, D.S. et al. Unconventional strategies for the suppression of allergic asthma. Curr. Drug Targets Inflamm. Allergy 2, 187-195 (2003).
15. Yiamouyiannis, C.A. et al. Shifts in lung lymphocyte profiles correlate with the sequential development of acute allergic and chronic tolerant stages in a murine asthma model. Am. J. Pathol. 154, 1911-1921 (1999).
16. Swirski, F.K. et al. Chronic exposure to innocuous antigen in sensitized mice leads to suppressed airway eosinophilia that is reversed by granulocyte macrophage colony-stimulating factor. J. Immunol. 169, 3499-3506 (2002).
17. Sakai, K. et al. Prolonged antigen exposure ameliorates airway inflammation but not remodeling in a mouse model of bronchial asthma. Int. Arch. Allergy Immunol. 126, 126-134 (2001).
18. Van Hove, C.L. et al. Prolonged inhaled allergen exposure can induce persistent tolerance. Am. J. Respir. Cell Mol. Biol. 36, 573-584 (2007).
19. Schramm, C.M. et al. Chronic inhaled ovalbumin exposure induces antigen-dependent but not antigen-specific inhalational tolerance in a murine model of allergic airway disease. Am. J. Pathol. 164, 295-304 (2004).
20. Kabbur, P.M. et al. Interleukin-10 does not mediate inhalational tolerance in a chronic model of ovalbumin-induced allergic airway disease. Cell Immunol. 239, 67-74 (2006).
21. Swirski, F.K. et al. Prolonged ovalbumin exposure attenuates airway hyperresponsiveness and Tcell function in mice. Int. Arch. Allergy Immunol. 141, 130-140 (2006).
22. Carson, W.F. et al. Accumulation of regulatory T cells in local draining lymph nodes of the lung correlates with spontaneous resolution of chronic asthma in a murine model. Int. Arch. Allergy Immunol. 145, 231-243 (2008).
23. Strickland, D.H. et al. Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells. J. Exp. Med. 203, 2649-2660 (2006).
24. Burchell, J.T. et al. Attenuation of allergen-induced airway hyperresponsiveness is mediated by airway regulatory Tcells. Am. J. Physiol. Lung Cell Mol. Physiol. 296, L307-L319 (2009).
25. Singh, A. et al. Regulatory role of B cells in amurine model of allergic airway disease. J. Immunol. 180, 7318-7326 (2008).
26. Niu, N. et al. A novel pathway that regulates inflammatory disease in the respiratory tract. J. Immunol. 178, 3846-3855 (2007).
27. Faustino, L. et al. Regulatory T cells migrate to airways via CCR4 and attenuate the severity of airway allergic inflammation. J. Immunol. 190, 2614-2621 (2013).
28. Kohm, A.P. et al. Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J. Immunol. 176, 3301-3305 (2006).
29. Couper, K.N. et al. Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malariainfected mice. J. Immunol. 178, 4136-4146 (2007).
30. Setiady, Y.Y., Coccia, J.A. & Park, P.U. In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. Eur. J. Immunol. 40, 780-786 (2010).
31. Bedoret, D. et al. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J. Clin. Invest. 119, 3723-3738 (2009).
32. Joetham, A. et al. Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGFbeta. J. Immunol. 178, 1433-1442 (2007).
33. Taylor, A.W. Review of the activation of TGF-beta in immunity. J. Leukoc. Biol. 85, 29-33 (2009).
34. Halwani, R. et al. Role of transforming growth factor-beta in airway remodeling in asthma. Am. J. Respir. Cell Mol. Biol. 44, 127-133 (2011).
35. Tong, J. et al. Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma. J. Exp. Med. 203, 1173-1184 (2006).
36. McGrath, E.E. et al. Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis. Thorax 67, 796-803 (2012).
37. Aggarwal, B.B. Signalling pathways of the TNF superfamily: a doubleedged sword. Nat. Rev. Immunol. 3, 745-756 (2003).
38. Rossi, D. & Gaidano, G. Messengers of cell death: apoptotic signaling in health and disease. Haematologica 88, 212-218 (2003).
39. Ishida, Y. et al. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887-3895 (1992).
40. Collison, A. et al. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat. Med. 19, 232-237 (2013).
41. Grimberg, A. et al. IGFBP-3 mediates p53-induced apoptosis during serum starvation. Int. J. Oncol. 21, 327-335 (2002).
42. Williams, A.C. et al. Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death Differ. 14, 137-145 (2007).
43. Johnson, C.R. & Jarvis,W.D. Caspase-9 regulation: an update. Apoptosis 9, 423-427 (2004).
44. Schneider, P. et al. Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Biol. Chem. 278, 5444-5454 (2003).
45. Davidson, N.J. et al. Chronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response. Int. Rev. Immunol. 19, 91-121 (2000).
46. Christ, M. et al. Immune dysregulation in TGF-beta 1-deficient mice. J. Immunol. 153, 1936-1946 (1994).
47. Kantarci, A. & Van Dyke, T.E. Lipoxins in chronic inflammation. Crit. Rev. Oral Biol. Med. 14, 4-12 (2003).
48. Moran, M. & Nicholson, P. Prostaglandin deficiency. Prostaglandins Leukot. Essent. Fatty Acids 39, 83-89 (1990).
49. Barnes, P.J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. 94, 557-572 (1998).
50. Wang, H. et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421, 384-388 (2003).
51. Shevach, E.M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25, 195-201 (2006).
52. Mauri, C. & Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221-241 (2012).
53. Fleming, B.D. & Mosser, D.M. Regulatory macrophages: setting the threshold for therapy. Eur. J. Immunol. 41, 2498-2502 (2011).
54. Chen, X., Armstrong, M.A. & Li, G. Mesenchymal stem cells in immunoregulation. Immunol. Cell Biol. 84, 413-421 (2006).
55. Savill, J. Apoptosis in resolution of inflammation. J. Leukoc. Biol. 61, 375-380 (1997).
56. Haslett, C. et al. Granulocyte apoptosis and the control of inflammation. Philos. Trans. R Soc. Lond. B Biol. Sci. 345, 327-333 (1994).
57. Kankaanranta, H. et al. Delayed eosinophil apoptosis in asthma. J. Allergy Clin. Immunol. 106, 77-83 (2000).
58. Maret, M. et al. A role for Bid in eosinophil apoptosis and in allergic airway reaction. J. Immunol. 182, 5740-5747 (2009).
59. de Souza, P.M. & Lindsay, M.A. Apoptosis as a therapeutic target for the treatment of lung disease. Curr. Opin. Pharmacol. 5, 232-237 (2005).
60. Saito, K. et al. Differential regulatory function of resting and preactivated allergen-specific CD4+ CD25+ regulatory T cells in Th2-type airway inflammation. J. Immunol. 181, 6889-6897 (2008).
61. Alcorn, J.F. et al. Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease. Am. J. Respir. Crit. Care Med. 176, 974-982 (2007).
62. McMillan, S.J., Xanthou, G.&Lloyd,C.M.Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J. Immunol. 174, 5774-5780 (2005).
63. Thomas, H.E. & Biden, T.J. Bad news for beta-cell apoptosis. Diabetes 58, 1725-1727 (2009).
64. Zhang, X.R. et al. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation. Cell Death Differ. 10, 203-210 (2003).
65. Grosse-Wilde, A. et al. TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development. J. Clin. Invest. 118, 100-110 (2008).
66. Hoffmann, O. et al. TRAIL limits excessive host immune responses in bacterial meningitis. J. Clin. Invest. 117, 2004-2013 (2007).
67. Cretney, E. et al. TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. Immunol. Cell Biol. 83, 511-519 (2005).
68. McGrath, E.E. et al. TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. J. Leukoc. Biol. 90, 855-865 (2011).
69. Robertson, N.M. et al. Differential expression ofTRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: evidence for a role of TRAIL in eosinophil survival. J. Immunol. 169, 5986-5996 (2002).
70. MacFarlane, M. TRAIL-induced signalling and apoptosis. Toxicol. Lett. 139, 89-97 (2003).
71. Weckmann, M. et al. Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease. Nat. Med. 13, 1308-1315 (2007).
72. Lorz, C. et al. Trail and kidney disease. Front Biosci. 14, 3740-3749 (2009).
73. Borges, V.M. et al. Fas ligand triggers pulmonary silicosis. J. Exp. Med. 194, 155-164 (2001).
74. Hameed, A.G. et al. Inhibition of tumor necrosis factor-related apoptosisinducing ligand (TRAIL) reverses experimental pulmonary hypertension. J. Exp. Med. 209, 1919-1935 (2012).
75. Steinwede, K. et al. TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice. J. Exp. Med. 209, 1937-1952 (2012).
76. Kayagaki, N. et al. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. J. Immunol. 162, 2639-2647 (1999).
77. Kayagaki, N. et al. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 94, 3914-3919 (1997).
78. Yamazaki, T. et al. Blockade of B7-H1 on macrophages suppresses CD4+ Tcell proliferation by augmenting IFN-gamma-induced nitric oxide production. J. Immunol. 175, 1586-1592 (2005).
79. Faustino, L. et al. Regulatory T cells accumulate in the lung allergic inflammation and efficiently suppress T-cell proliferation but not Th2 cytokine production. Clin. Dev. Immunol. 2012, 721817 (2012).